Investor Database — 54,000+ VC, PE & angel contacts, the full list for $19.Get the list

Sherpa Healthcare Partners

Private Equity Beijing, China ·Founded 2018

Overview

Sherpa Healthcare Partners is a Beijing-based private equity firm specializing in healthcare investments across China and the United States. The firm focuses on early to growth-stage investments in the pharmaceutical, biotechnology, medical technology, and healthcare services sectors. Their portfolio includes companies in gene technology and related industries. The firm's investment strategy encompasses a wide range of stages, from seed and early-stage ventures to growth, late-stage, pre-IPO, and buyout opportunities. This approach allows them to support companies at various points in their development, providing tailored resources and expertise to foster growth and innovation. Sherpa Healthcare Partners has established a robust portfolio, fostering enduring value and collaborative partnerships within the healthcare industry. Their commitment to building lasting connections enables them to provide comprehensive, all-cycle services that leverage essential resources for their portfolio companies.

Investment Focus

Focus on healthcare sectors
Early to growth-stage companies
Presence in China or the United States

Portfolio Companies

Appia BioAlamar BiosciencesMattermarkArchimedes VascularAusperBio

Reach Sherpa Healthcare Partners directly

Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.

Unlock full contacts →

Frequently asked questions about Sherpa Healthcare Partners

What sectors does Sherpa Healthcare Partners invest in?

Sherpa Healthcare Partners invests in Healthcare Services, Pharmaceuticals, Biotechnology, Medical Technology and Gene Technology, and is based in Beijing, China. Sherpa Healthcare Partners is listed as a private equity in the ConnectSafely investor database.